Orion Corporation
From Infogalactic: the planetary knowledge core
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
 |
|
| Julkinen osakeyhtiö | |
| Traded as | OMX: ORNBV |
| Industry | Pharmaceutical industry |
| Founded | 1917 |
| Headquarters | Espoo, Finland |
|
Key people
|
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman) |
| Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
| Revenue | €1006.9 million (2013)[1] |
| €267.7 million (2013)[2] | |
| Profit | €206.2 million (2013)[3] |
| Total assets | €979.0 million (2013)[4] |
| Total equity | €513.9 million (2013)[5] |
|
Number of employees
|
3,519 (2013)[6] |
| Website | www.orion.fi |
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.
Orion's class A and B shares are listed on the Helsinki Stock Exchange.
Products
-
This list is incomplete; you can help by expanding it.
|
References
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ↑ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
